E3 Ligase

Ubiquitin modification of substrate proteins is achieved by the activity of E1 activating, E2 conjugating and E3 ligase enzymes. Substrate proteins can be modified with one (mono-ubiquitination) or many (poly-ubiquitination) molecules of ubiquitin, and each type of modification has distinct regulatory fates. E3 ligases number in the thousands and have the highest level of specificity for the target protein to be modified by ubiquitin or ubiquitin-like modifiers (UBL).


Accessory Proteins
AP-100

HSP70/HSPA1A

Human recombinant

50 µg, 100 µg

$295.00 $365.00 Buy / Info
AP-110

DNAJB1/HSP40

Human recombinant

50 µg

$165.00 Data Sheet Buy / Info
AP-120

E6, Human Papillomavirus type 16

Viral Recombinant

25 μg

$129.00 Data Sheet Buy / Info
AP-140

HSP60/HSPD1

Human recombinant

50 µg